Canada markets close in 4 hours 16 minutes

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0550-0.0150 (-21.43%)
As of 11:29AM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 4.55M
Enterprise Value 4.56M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.15
Price/Book (mrq)N/A
Enterprise Value/Revenue 12.89
Enterprise Value/EBITDA -68.99

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3-54.84%
S&P500 52-Week Change 324.16%
52 Week High 30.2500
52 Week Low 30.0400
50-Day Moving Average 30.0701
200-Day Moving Average 30.1204

Share Statistics

Avg Vol (3 month) 310.45k
Avg Vol (10 day) 313.25k
Shares Outstanding 565M
Implied Shares Outstanding 665M
Float 823.06M
% Held by Insiders 162.69%
% Held by Institutions 10.00%
Shares Short (Jan 31, 2024) 4605
Short Ratio (Jan 31, 2024) 40.1
Short % of Float (Jan 31, 2024) 40.00%
Short % of Shares Outstanding (Jan 31, 2024) 40.00%
Shares Short (prior month Dec 29, 2023) 47.3k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 10, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug 10, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin -19.59%
Operating Margin (ttm)-368.05%

Management Effectiveness

Return on Assets (ttm)-232.72%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)353.74k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)N/A
EBITDA -1.47M
Net Income Avi to Common (ttm)-69.29k
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)32.48k
Total Cash Per Share (mrq)0
Total Debt (mrq)811.38k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.13
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)-1.99M
Levered Free Cash Flow (ttm)-1.15M